🎊🎉We are delighted to announce the official launch of our brand new website!!!🎉🎊 💻ioclinicalnetwork.co.uk 🚨A dedicated platform to support those delivering immunotherapy to patients across the UK and beyond. 📄Up-to-date clinical guidance and protocols 🎓Education and

We are live at #UKOF25. Come and see us at our stand just outside Studio 1. Lot's of IOCN updates and also the obligatory freebies! The Immunobuddies Podcast Anna Olsson-Brown Ricky Frazer

🧬 HLH UNFILTERED: Breaking Down the Beast Immunobuddies Podcast | Episode 147 Out Now! Still trying to wrap your head around HLH? In part 2 of our HLH series, we’re diving into the nuts and bolts: 🔬 What are the components of HLH? ⚠️ What abnormalities actually show up in

🎧 New Episode Alert! Episode 149: HLH – H-Score Demystified (Part 4) 🔥 Available now on Spotify, Apple Podcasts, and all major platforms. Ever wondered when to order a bone marrow in suspected HLH? 🤔 Or whether procalcitonin can really help differentiate inflammation from

We are under way at Hilton Leeds City diving into Capacity Management in Immuno-Oncology Service Delivery. Another fantastic turn-out — great to see so many colleagues passionate about improving cancer services! 💬🧬 #ImmunoOncology #CancerCare #Oncology #HealthInnovation

It’s the hot topic in Immunotherapy right now 🔥 Anna Olsson-Brown has just been discussing the impact of managing HLH within our service — perfect timing from the @Immunbuddies team! 🎧 A must-listen for anyone in #ImmunoOncology. #HLH #CancerCare #IO #IOServiceDelivery #Oncology

🌟Now hearing from Ali Hodge, Nurse Consultant in Immunotherapy at University Hospitals Sussex, on Implementing a Comprehensive Delivery and Support Approach to Immunotherapies. Inspiring insight into building sustainable, patient-focused IO services 👏🧬 #Immunotherapy

🌟Next up: Trudy Guinan, Immunotherapy Nurse Consultant from The Clatterbridge Cancer Centre, sharing her experience on Establishing Your Immuno-Oncology Team: Meeting Workforce and Capacity Challenges. Valuable insights on building resilient, future-ready IO services, with an

☀️This afternoon kicks off with Dr Clare Barlow, Consultant Medical Oncologist at Somerset NHS Foundation Trust, discussing Standardising Training to Manage the Growing Complexity of Immunotherapies. A vital conversation as IO continues to evolve and expand 🔄🧠

Now hearing from Lucy Ford, Advanced Nurse Practitioner from Somerset, on Developing and Expanding Your Service to Meet Capacity Challenges. Practical strategies for scaling IO delivery while maintaining high-quality patient care, and future proofing your service. 💡👩‍⚕️

🚨 Email Service Disruption 🚨 We're currently experiencing technical issues with our email system and are unable to send or receive messages at this time. Our team is working to resolve the issue as quickly as possible. We apologise for any inconvenience and appreciate your

🎧 NEW EPISODE OUT NOW! Is Subcutaneous Immunotherapy a Game-Changer or Just Hype? 💉🤔 Join Ricky Frazer & Anna Olsson-Brown as they unpack the science, promise & pitfalls of Subcutaneous Immunotherapy with special guests Jo Parkes & Dr Vasiliki Michalarea. We’re diving into:

🛠️ 💻 MAINTENANCE WORK: Sat 19 Jul 2025 from 08:00 to 18:00 🔴 Our website and email services are currently down for routine server maintenance. We anticipate this to be resolved by 6PM this evening. We apologise for any inconvenience caused. The IOCN Team

💻 📅 Our webinar schedule is now available until October 2025. 👀 Check out the schedule and register today: tinyurl.com/2xp73ya9 ✨ Exciting updates include the launch of our brand new Spotlight Webinar Series in August, and the eagerly anticipated launch of our Service

🚨As part of the E-IMMUNE research programme, Dr Anna Olsson-Brown, Professor Janet Brown and Dr Joanne Bird are leading a group looking into the various elements of immunotherapy tolerability and developing a digital platform to monitor the late effects of immunotherapy

🚨 BOPA survey on monitoring and treatments for immune related myocarditis! 📋 The BOPA Immunotherapy Specialist Interest Group invites healthcare professionals to collaborate with us by completing this survey relating to access to drugs for IR-myocarditis. 🔗Find out more and

🎓IOCN Advance the management of immunotherapy toxicities through case conundrums 📅 Friday 3rd October 2025 | 🕤 09:30–16:30 📍 Macdonald Burlington Hotel, Birmingham 🎟️ Tickets: £150pp | CPD Accredited (6.5 hours) 🔗 Book now: tinyurl.com/kw3jce9k 💥 Join us for a day of

🚨 NEW WEBINAR SERIES ALERT! 🚨 The Immuno-Oncology Clinical Network is proud to launch our brand-new "Spotlight" Webinar Series – shining a light on key developments, challenges, and innovations in immuno-oncology. 🔦 First up: 🗓️ 19th August 2025 🕡 18:30 (BST) 📢

📢 DEADLINE EXTENDED! CALL FOR ABSTRACTS – Share Your Expertise! Got a compelling case study on immunotherapy toxicity (IO toxicity)? We want to hear from you! We’re especially looking for: 📷 Unique or complex irAEs 📷 Multidisciplinary approaches to management 🗓️ New